Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Laser therapy for central retinal vein obstruction.

D Finkelstein1

  • 1Wilmer Ophthalmological Institute, Johns Hopkins Hospital, Baltimore, MD 21287-9227, USA.

Current Opinion in Ophthalmology
|May 7, 1996
PubMed
Summary

Central vein occlusion can progress to nonperfusion within months. Laser treatments for macular edema and iris neovascularization show specific efficacies, while new venous anastomosis techniques offer potential benefits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells.

Oncogene·2017
Same author

MYCN induces neuroblastoma in primary neural crest cells.

Oncogene·2017
Same author

PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.

Cell death & disease·2016
Same author

Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy.

British journal of cancer·2014
Same author

Orthotopic models of pediatric brain tumors in zebrafish.

Oncogene·2014
Same author

Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer.

British journal of cancer·2009

Area of Science:

  • Ophthalmology
  • Retinal Vascular Diseases

Background:

  • Central retinal vein occlusion (CRVO) is a significant cause of vision loss.
  • Early natural history studies indicate a notable rate of perfusion to nonperfusion conversion within months of CRVO onset.
  • Previous research explored laser photocoagulation for CRVO complications.

Purpose of the Study:

  • To evaluate the efficacy of laser photocoagulation for macular edema and iris neovascularization in CRVO patients.
  • To investigate the natural history of CRVO, including perfusion status changes.
  • To explore novel interventions like chorioretinal venous anastomosis for CRVO management.

Main Methods:

  • Analysis of data from the Collaborative Central Retinal Vein Occlusion Study (CCRVOS).
  • Randomized trial comparing laser photocoagulation strategies.

Related Experiment Videos

  • Observation of early natural history and outcomes.

    • Main Results:

    • Grid laser photocoagulation did not improve visual acuity in cases of perfused macular edema.
    • Panretinal photocoagulation is recommended for iris neovascularization management post-appearance.
    • A 16% conversion from perfusion to nonperfusion occurred within 4 months in early CRVO stages.

    Conclusions:

    • Specific laser photocoagulation approaches are indicated for CRVO complications.
    • Chorioretinal venous anastomosis presents a potential therapeutic avenue for improving venous outflow and visual acuity in CRVO.
    • Understanding CRVO natural history is crucial for timely and effective treatment strategies.